Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q1)Sep 30, 2025 | (FY)Jun 30, 2025 | (Q4)Jun 30, 2025 | (Q3)Mar 31, 2025 | (Q2)Dec 31, 2024 | (Q1)Sep 30, 2024 | (FY)Jun 30, 2024 | (Q4)Jun 30, 2024 | (Q3)Mar 31, 2024 | (Q2)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 78.41%88.11M | 55.58%353.47M | 135.79%134.95M | 18.87%89.17M | 63.93%80.05M | 7.00%49.39M | 33.02%227.19M | 26.51%57.23M | 68.35%75.01M | 21.37%48.83M |
| Cost of revenue | 77.21%73.56M | 58.52%303.97M | 162.11%115.81M | 19.69%79.74M | 68.77%70.07M | 5.25%41.51M | 32.29%191.75M | 17.88%44.18M | 73.90%66.62M | 21.94%41.52M |
| Gross profit | 84.74%14.55M | 39.67%49.5M | 46.66%19.14M | 12.41%9.43M | 36.46%9.98M | 17.32%7.88M | 37.11%35.44M | 68.17%13.05M | 34.33%8.39M | 18.22%7.31M |
| Operating expense | 16.54%3.59M | 23.90%13.32M | -3.73%4.31M | 4.25%2.45M | 11.87%3.07M | 26.89%3.08M | -0.14%10.75M | 46.21%4.47M | -28.56%2.35M | 16.25%2.75M |
| Selling and administrative expenses | 24.40%5.2M | 43.25%18.99M | 24.62%6.84M | 3.64%3.59M | 19.72%4.51M | 31.73%4.18M | 9.96%13.26M | 77.64%5.49M | -8.58%3.46M | 34.73%3.77M |
| -General and administrative expense | 24.40%5.2M | 43.25%18.99M | 24.62%6.84M | 3.64%3.59M | 19.72%4.51M | 31.73%4.18M | 9.96%13.26M | 77.64%5.49M | -8.58%3.46M | 34.73%3.77M |
| Other operating expenses | ---- | -9.61%1.4M | ---- | ---- | ---- | ---- | 70.64%1.55M | ---- | ---- | ---- |
| Total other operating income | 46.36%1.61M | 74.30%7.07M | 149.70%2.53M | 2.34%1.14M | 40.88%1.44M | 47.45%1.1M | 84.40%4.06M | 8.15%1.01M | 124.70%1.11M | 135.57%1.02M |
| Operating profit | 128.45%10.97M | 46.53%36.18M | 72.93%14.83M | 15.59%6.98M | 51.26%6.91M | 11.91%4.8M | 63.69%24.69M | 82.46%8.58M | 104.54%6.04M | 19.43%4.57M |
| Net non-operating interest income (expenses) | -216.02%-1.38M | -98.62%-3.19M | -163.58%-1.25M | 15.78%-363K | 28.93%-258K | -27.03%-437K | -29.35%-1.61M | -41.18%-475K | -86.58%-431K | -4.31%-363K |
| Non-operating interest expense | 216.02%1.38M | 249.45%1.6M | 163.58%1.25M | -15.78%363K | -28.93%258K | 27.03%437K | 20.09%459.28K | 190.90%475K | 86.58%431K | 4.31%363K |
| Total other finance cost | ---- | 38.20%1.58M | ---- | ---- | ---- | ---- | 33.48%1.15M | ---- | ---- | ---- |
| Net investment income | ||||||||||
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | ||||||||||
| Income from associates and other participating interests | -354K | -7,001,500.00%-210.05K | -72K | -51K | -87K | 0 | -3 | 0 | 0 | 0 |
| Special income (charges) | -446.38%-6.22M | -5.12M | -153.24%-1.14M | 0 | ||||||
| Less:Write off | ---- | 446.38%6.22M | --5.12M | ---- | ---- | ---- | 153.24%1.14M | --0 | ---- | ---- |
| Other non-operating income (expenses) | ||||||||||
| Income before tax | 111.57%9.23M | 21.04%26.57M | 3.53%8.39M | 17.09%6.56M | 56.11%6.56M | 10.59%4.36M | 63.87%21.95M | 106.93%8.1M | 106.07%5.61M | 20.94%4.2M |
| Income tax | 200.29%3.11M | 11.16%6.49M | -42.97%1.31M | 5.00%1.58M | 75.36%1.82M | 5.18%1.04M | 74.68%5.84M | 185.90%2.3M | 83.82%1.5M | 17.67%1.04M |
| Net income | 83.99%6.13M | 24.62%20.08M | 21.93%7.08M | 21.51%4.99M | 49.79%4.74M | 12.39%3.33M | 60.28%16.11M | 86.55%5.81M | 115.60%4.11M | 22.06%3.17M |
| Net income continuous operations | 83.99%6.13M | 24.62%20.08M | 21.93%7.08M | 21.51%4.99M | 49.79%4.74M | 12.39%3.33M | 60.28%16.11M | 86.55%5.81M | 115.60%4.11M | 22.06%3.17M |
| Noncontrolling interests | -700.00%-72K | -1,668.96%-135.4K | -26K | -2,300.00%-48K | -180.00%-14K | -9K | 72.24%-7.65K | 0 | -2K | -66.67%-5K |
| Net income attributable to the company | 85.65%6.2M | 25.40%20.21M | 22.37%7.11M | 22.62%5.04M | 50.00%4.76M | 12.69%3.34M | 59.92%16.12M | 85.15%5.81M | 115.70%4.11M | 22.11%3.17M |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | 85.65%6.2M | 25.40%20.21M | 22.37%7.11M | 22.62%5.04M | 50.00%4.76M | 12.69%3.34M | 59.92%16.12M | 85.15%5.81M | 115.70%4.11M | 22.11%3.17M |
| Gross dividend payment | ||||||||||
| Basic earnings per share | 70.00%0.0136 | 20.87%0.0475 | 12.68%0.016 | 17.65%0.012 | 42.50%0.0114 | 5.26%0.008 | 50.57%0.0393 | 75.31%0.0142 | 108.16%0.0102 | 19.40%0.008 |
| Diluted earnings per share | 76.06%0.0125 | 25.29%0.0431 | 17.74%0.0146 | 17.98%0.0105 | 44.29%0.0101 | 9.23%0.0071 | 37.60%0.0344 | 77.14%0.0124 | 81.63%0.0089 | 4.48%0.007 |
| Dividend per share | 0 | 340.00%0.022 | 0 | 0 | 0.015 | 40.00%0.007 | 0.005 | 0 | 0 | 0 |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.